The Trump administration issued an executive order Sunday that would significantly change how Medicare pays for certain prescription drugs. The “Most Favored Nation” policy would tie Medicare drug reimbursement for certain drugs under Part B and D t o that of prices paid in select foreign countries.

Washington, D.C.—Patient groups representing millions of people with serious health conditions submitted an amicus brief today urging the full U.S. Court of Appeals for the D.C. Circuit to hear the case against a federal rule expanding the availability of short-term limited-duration insurance (STLDI) plans. The request

WASHINGTON, D.C. – U.S. Department of Health and Human Services (HHS) announced their decision Wednesday to rescind all guidance related to U.S. Food and Drug Administration (FDA) oversight of laboratory developed tests (LDTs), a move that could have broad, negative health consequences. The following is a statement from Lisa Lacasse,